response of braf-mutated spindle cell sarcoma to braf/mek inhibitors | oncotarget
Published 3 months ago • 102 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
1:21
intrathoracic synovial sarcoma with braf v600e mutation | oncotarget
-
1:22
braf mutations and mek inhibitors
-
1:35:47
braf-mutated mcrc: from diagnosis to treatment
-
6:33
treatment of braf-mutant metastatic melanoma
-
1:55
dr. lieu on the predictive value of braf v600e mutations in crc
-
0:52
dr. kudchadkar on combining braf and mek inhibitors to treat melanoma
-
2:52
birma trial: is braf and mek inhibition successful in relapsed mm?
-
1:22
surpass: evaluating the next-generation of spear t-cell therapy
-
3:26
braf/mek inhibition among patients with papillary craniopharyngiomas
-
23:56
braf explained in plain english
-
0:58
further investigation of veliparib underway for glioblastoma
-
1:26
braf-mutated aml is associated with poor prognosis and myelodysplasia-related mutations
-
1:16
evaluating the prevalence of braf v600e mutations in glioblastoma
-
15:57
braf mutation – what does it mean? what are the complications of braf inhibitors?
-
2:45
ulixertinib in tumors with braf fusions, non-v600e or non-v600k braf mutations
-
2:21
vs-6766, a unique inhibitor of the raf/mek signaling pathway for patients with kras mutant tumors
-
18:36
breakdown of braf testing and implications
-
1:06
scott kopetz, md, explains how braf mutations figure into treatment algorithms for crc
-
1:43
ddpcr detects kit d816v mutations with high sensitivity in systemic mastocytosis